BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11775935)

  • 1. Protease inhibitors in children: combination therapy reduced death by two thirds.
    James JS
    AIDS Treat News; 2001 Nov; (374):4-5. PubMed ID: 11775935
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved AIDS treatments bring life and hope--at a cost.
    Brink S
    US News World Rep; 2001 Jan; 130(4):44-6. PubMed ID: 11211336
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV's potent cocktail.
    Lusky K
    Contemp Longterm Care; 1999 Dec; 22(12):59. PubMed ID: 10977335
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent developments in antiretroviral therapy.
    DeSimone GA
    Clin J Oncol Nurs; 2001; 5(6):266, 275. PubMed ID: 11899628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A French lesson. French experience shows full funding of treatment advances saves money.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):49. PubMed ID: 11364203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How HIV drugs work 101.
    Pietrandoni G
    Posit Aware; 2001; 12(5):26-7. PubMed ID: 11688481
    [No Abstract]   [Full Text] [Related]  

  • 7. Rescue regimens: the value of protease-inhibitor boosting.
    Segal-Maurer S; Schütz M
    Body Posit; 2001 Sep; 14(9):11-3. PubMed ID: 11693112
    [No Abstract]   [Full Text] [Related]  

  • 8. The end of AIDS?
    Leland J
    Newsweek; 1996 Dec; 128(23):64-8, 71, 73. PubMed ID: 10162943
    [No Abstract]   [Full Text] [Related]  

  • 9. Consider these initial combination regimens.
    AIDS Alert; 2010 Apr; 25(4):40. PubMed ID: 20556895
    [No Abstract]   [Full Text] [Related]  

  • 10. The ever-changing HIV treatment landscape.
    Berger DS
    Posit Aware; 2003; 14(1):69-70, 76. PubMed ID: 12630378
    [No Abstract]   [Full Text] [Related]  

  • 11. ABC in the news.
    Carter M
    IAPAC Mon; 2006 Jun; 12(6):178-9. PubMed ID: 17233104
    [No Abstract]   [Full Text] [Related]  

  • 12. Protease inhibitors: opium of the masses?
    Martinez LJ
    Res Initiat Treat Action; 2000 Sep; 6(3):7-11. PubMed ID: 11708167
    [No Abstract]   [Full Text] [Related]  

  • 13. Teaching adherence to substance users.
    TreatmentUpdate; 2002; 14(4):4-5. PubMed ID: 12064315
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
    TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
    [No Abstract]   [Full Text] [Related]  

  • 15. New versions of antiretroviral guidelines contain some important changes.
    Murphy MJ
    Fac Notes (New Orleans La); 1999; 11(4):1-3. PubMed ID: 11810843
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
    TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV integrase inhibitors show potent activity in clinical trials.
    Winslow DL
    AIDS Alert; 2007 Jan; 22(1):10-1. PubMed ID: 17722343
    [No Abstract]   [Full Text] [Related]  

  • 18. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
    Wilkins E
    J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV agents. Atazanavir and saquinavir.
    TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV drug update.
    Proj Inf Perspect; 2000 Mar; (29):6-7. PubMed ID: 12769050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.